JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.095x

Based on the latest financial reports, JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) has a cash flow conversion efficiency ratio of 0.095x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs3.62 Billion ≈ $39.19 Million USD) by net assets (Rs38.06 Billion ≈ $411.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See JB Chemicals & Pharmaceuticals Limited (JBCHEPHARM) net asset quality to measure how much of total assets are equity-financed.

JB Chemicals & Pharmaceuticals Limited - Cash Flow Conversion Efficiency Trend (2006–2026)

This chart illustrates how JB Chemicals & Pharmaceuticals Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check JBCHEPHARM operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.

JB Chemicals & Pharmaceuticals Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of JB Chemicals & Pharmaceuticals Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Silgan Holdings Inc
NYSE:SLGN
-0.345x
De Grey Mining Ltd
AU:DEG
0.000x
Minor International Public Company Limited
BK:MINT
0.094x
Navin Fluorine International Limited
NSE:NAVINFLUOR
0.071x
JUSUNG ENGINEERING Co. Ltd
KQ:036930
-0.027x
Corporacion America Airports
NYSE:CAAP
0.054x
Tanger Factory Outlet Centers Inc
NYSE:SKT
0.055x
Farsoon Technology Co. Ltd. A
SHG:688433
N/A

Annual Cash Flow Conversion Efficiency for JB Chemicals & Pharmaceuticals Limited (2006–2026)

The table below shows the annual cash flow conversion efficiency of JB Chemicals & Pharmaceuticals Limited from 2006 to 2026. For the full company profile with market capitalisation and key ratios, see market value of JB Chemicals & Pharmaceuticals Limited.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs41.59 Billion
≈ $449.80 Million
Rs7.11 Billion
≈ $76.85 Million
0.171x -35.00%
2025-03-31 Rs34.33 Billion
≈ $371.30 Million
Rs9.02 Billion
≈ $97.60 Million
0.263x -4.02%
2024-03-31 Rs29.23 Billion
≈ $316.15 Million
Rs8.01 Billion
≈ $86.58 Million
0.274x +8.58%
2023-03-31 Rs24.80 Billion
≈ $268.24 Million
Rs6.26 Billion
≈ $67.66 Million
0.252x +217.05%
2022-03-31 Rs21.39 Billion
≈ $231.28 Million
Rs1.70 Billion
≈ $18.40 Million
0.080x -54.17%
2021-03-31 Rs18.13 Billion
≈ $196.12 Million
Rs3.15 Billion
≈ $34.04 Million
0.174x -9.35%
2020-03-31 Rs14.38 Billion
≈ $155.51 Million
Rs2.75 Billion
≈ $29.78 Million
0.191x +47.08%
2019-03-31 Rs14.83 Billion
≈ $160.37 Million
Rs1.93 Billion
≈ $20.88 Million
0.130x +52.83%
2018-03-31 Rs14.44 Billion
≈ $156.20 Million
Rs1.23 Billion
≈ $13.31 Million
0.085x -41.88%
2017-03-31 Rs13.66 Billion
≈ $147.71 Million
Rs2.00 Billion
≈ $21.65 Million
0.147x +14.95%
2016-03-31 Rs10.95 Billion
≈ $118.46 Million
Rs1.40 Billion
≈ $15.10 Million
0.128x +0.15%
2015-03-31 Rs9.95 Billion
≈ $107.59 Million
Rs1.27 Billion
≈ $13.70 Million
0.127x +1049.86%
2014-03-31 Rs10.43 Billion
≈ $112.78 Million
Rs-139.78 Million
≈ $-1.51 Million
-0.013x -116.10%
2013-03-31 Rs10.20 Billion
≈ $110.34 Million
Rs849.32 Million
≈ $9.19 Million
0.083x -90.82%
2012-03-31 Rs9.70 Billion
≈ $104.90 Million
Rs8.80 Billion
≈ $95.14 Million
0.907x +368.67%
2011-03-31 Rs6.92 Billion
≈ $74.79 Million
Rs1.34 Billion
≈ $14.47 Million
0.194x -9.87%
2010-03-31 Rs5.68 Billion
≈ $61.44 Million
Rs1.22 Billion
≈ $13.19 Million
0.215x +10.50%
2009-03-31 Rs4.69 Billion
≈ $50.71 Million
Rs911.05 Million
≈ $9.85 Million
0.194x +210.91%
2008-03-31 Rs4.53 Billion
≈ $48.99 Million
Rs283.11 Million
≈ $3.06 Million
0.062x +17.36%
2007-03-31 Rs4.18 Billion
≈ $45.26 Million
Rs222.82 Million
≈ $2.41 Million
0.053x -21.99%
2006-03-31 Rs3.30 Billion
≈ $35.73 Million
Rs225.51 Million
≈ $2.44 Million
0.068x --

About JB Chemicals & Pharmaceuticals Limited

NSE:JBCHEPHARM India Drug Manufacturers - Specialty & Generic
Market Cap
$4.18 Billion
Rs386.77 Billion INR
Market Cap Rank
#3965 Global
#181 in India
Share Price
Rs2408.90
Change (1 day)
-3.87%
52-Week Range
Rs1656.70 - Rs2506.00
All Time High
Rs2506.00
About

J. B. Chemicals & Pharmaceuticals Limited manufactures and markets pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients (API) in India and internationally. The company's API product portfolio includes diclofenac sodium, diethylamine, acid, and potassium; and nifedipine, atenolol, and cilnidipine; and ciprofloxacin, cetirizine, and meclizine HCI. It also provides dos… Read more